China Digest: CassTime nets $30m led by Source Code; Denovo raises $46m

China Digest: CassTime nets $30m led by Source Code; Denovo raises $46m

CassTime

B2B automotive aftermarket platform CassTime has garnered $35 million in a Series C3 round funding led by Source Code Capital, while Denovo Biopharma has pocketed nearly 300 million yuan ($46 million) in a Series D round co-led by CICC Qide and Yingke PE.